Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Developmental biology. Pluripotent chromatin state.

Chi AS, Bernstein BE.

Science. 2009 Jan 9;323(5911):220-1. doi: 10.1126/science.1166261. No abstract available.

2.

Control of embryonic stem cell identity by nucleosome remodeling enzymes.

Fazzio TG, Panning B.

Curr Opin Genet Dev. 2010 Oct;20(5):500-4. doi: 10.1016/j.gde.2010.08.001. Epub 2010 Aug 25. Review.

3.

Parallel gateways to pluripotency: open chromatin in stem cells and development.

Koh FM, Sachs M, Guzman-Ayala M, Ramalho-Santos M.

Curr Opin Genet Dev. 2010 Oct;20(5):492-9. doi: 10.1016/j.gde.2010.06.002. Epub 2010 Jul 2. Review.

4.

Chromatin features and the epigenetic regulation of pluripotency states in ESCs.

Tee WW, Reinberg D.

Development. 2014 Jun;141(12):2376-90. doi: 10.1242/dev.096982. Review.

5.

Epigenetic control of embryonic stem cell fate.

Christophersen NS, Helin K.

J Exp Med. 2010 Oct 25;207(11):2287-95. doi: 10.1084/jem.20101438. Review.

6.

Global transcription in pluripotent embryonic stem cells.

Efroni S, Duttagupta R, Cheng J, Dehghani H, Hoeppner DJ, Dash C, Bazett-Jones DP, Le Grice S, McKay RD, Buetow KH, Gingeras TR, Misteli T, Meshorer E.

Cell Stem Cell. 2008 May 8;2(5):437-47. doi: 10.1016/j.stem.2008.03.021.

7.

Chromatin remodeling in embryonic stem cells: regulating the balance between pluripotency and differentiation.

Keenen B, de la Serna IL.

J Cell Physiol. 2009 Apr;219(1):1-7. doi: 10.1002/jcp.21654. Review.

PMID:
19097034
8.

NuRD and pluripotency: a complex balancing act.

Hu G, Wade PA.

Cell Stem Cell. 2012 May 4;10(5):497-503. doi: 10.1016/j.stem.2012.04.011. Review.

9.

Investigating the bona fide differentiation capacity of human pluripotent stem cells.

Heng JC, Loh KM, Ng HH.

Cell Res. 2012 Jan;22(1):6-8. doi: 10.1038/cr.2011.142. Epub 2011 Aug 30. No abstract available.

10.

Developmental biology. Combing over the Polycomb group proteins.

Marx J.

Science. 2005 Apr 29;308(5722):624-6. No abstract available.

PMID:
15860605
11.

ATP dependent chromatin remodeling enzymes in embryonic stem cells.

Saladi SV, de la Serna IL.

Stem Cell Rev. 2010 Mar;6(1):62-73. doi: 10.1007/s12015-010-9120-y. Review.

12.

Development. Gene-suppressing proteins reveal secrets of stem cells.

Holden C.

Science. 2006 Apr 21;312(5772):349. No abstract available.

PMID:
16627706
13.

Factor mediated gene priming in pluripotent stem cells sets the stage for lineage specification.

Dillon N.

Bioessays. 2012 Mar;34(3):194-204. doi: 10.1002/bies.201100137. Epub 2012 Jan 13. Review.

PMID:
22247014
14.

TIF1beta regulates the pluripotency of embryonic stem cells in a phosphorylation-dependent manner.

Seki Y, Kurisaki A, Watanabe-Susaki K, Nakajima Y, Nakanishi M, Arai Y, Shiota K, Sugino H, Asashima M.

Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):10926-31. doi: 10.1073/pnas.0907601107. Epub 2010 May 27. Erratum in: Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13556.

15.

Concise review: epigenetic mechanisms contribute to pluripotency and cell lineage determination of embryonic stem cells.

Gan Q, Yoshida T, McDonald OG, Owens GK.

Stem Cells. 2007 Jan;25(1):2-9. Epub 2006 Oct 5. Review.

16.

Comparative FAIRE-seq analysis reveals distinguishing features of the chromatin structure of ground state- and primed-pluripotent cells.

Murtha M, Strino F, Tokcaer-Keskin Z, Sumru Bayin N, Shalabi D, Xi X, Kluger Y, Dailey L.

Stem Cells. 2015 Feb;33(2):378-91. doi: 10.1002/stem.1871.

17.

Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cells.

Yang J, Chai L, Fowles TC, Alipio Z, Xu D, Fink LM, Ward DC, Ma Y.

Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19756-61. doi: 10.1073/pnas.0809321105. Epub 2008 Dec 5.

18.

Molecular basis of pluripotency.

Chen L, Daley GQ.

Hum Mol Genet. 2008 Apr 15;17(R1):R23-7. doi: 10.1093/hmg/ddn050. Review.

PMID:
18632692
19.

Pluripotency maintenance mechanism of embryonic stem cells and reprogramming.

Masui S.

Int J Hematol. 2010 Apr;91(3):360-72. doi: 10.1007/s12185-010-0517-9. Epub 2010 Feb 16. Review.

PMID:
20157790
20.

The use of signalling pathway inhibitors and chromatin modifiers for enhancing pluripotency.

Sumer H, Liu J, Verma PJ.

Theriogenology. 2010 Sep 1;74(4):525-33. doi: 10.1016/j.theriogenology.2010.05.030. Epub 2010 Jul 7. Review.

PMID:
20615537

Supplemental Content

Support Center